CPRX icon

Catalyst Pharmaceutical
CPRX

Overview Fund Activity

143 hedge funds and large institutions have $345M invested in Catalyst Pharmaceutical in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 53 reducing their positions, and 15 closing their positions.

Holders
143
Holders Change
+5
Holders Change %
+3.62%
% of All Funds
2.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
43
Reduced
53
Closed
15
Calls
$491K
Puts
$1.11M
Net Calls
-$622K
Net Calls Change
+$1.32M

Top Buyers

1
LSV Asset Management
1
LSV Asset Management
Illinois
$27.9M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$7.6M
3
Aviva
3
Aviva
United Kingdom
$1.73M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$9.29M
5
CIC
5
Cornercap Investment Counsel
Georgia
$1.15M

Top Sellers

1
ACP
1
Acuta Capital Partners
California
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$3.79M
3
GC
3
Globeflex Capital
California
$1.61M
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$2.15M
5
Prudential Financial
5
Prudential Financial
New Jersey
$8.78M
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
151
Brookstone Capital Management
Illinois
– -$91K -16,472 Closed
VF
152
Virtu Financial
New York
– -$76K -13,295 Closed
Principal Financial Group
153
Principal Financial Group
Iowa
– -$64K -11,205 Closed
PCM
154
Pinz Capital Management
New York
– -$22K -3,900 Closed
PAM
155
Panagora Asset Management
Massachusetts
– -$10K -1,780 Closed
3 4 5 6
7